Hypothesis. The following studies were designed to test the hypothesis that simultaneous administration of either Ang(1-7) or its antagonist A-779 would affect the chronic hypertensive effects of angiotensin II (Ang II).
Introduction. Despite the well-described actions of Ang(1-7) and its role possessing opposite actions to Ang II, there have been few studies examining the role of Ang(1-7) in a chronic setting. It is well established that Ang(1-7) plays a protective role in preventing deleterious effects of Ang II in the heart, but little is known of its role in modulating the chronic hypertensive effects of Ang II.
Materials and methods. Rats were instrumented with venous catheters and telemetric pressure transducers. Arterial pressure responses were measured in rats treated with Ang II (10 ng/kg/ min) (n=9) and compared with those treated with Ang II and Ang(1-7) (24 µg/kg/h) (n=8), or the Ang(1-7) antagonist A-779 (24 µg/kg/h) (n=7) for 8 days.
Results. Mean arterial pressure rose significantly and similarly in all three groups of rats, such that by day 8 of Ang II infusion, pressures had risen 25—30 mmHg in all rats.
Conclusions. These results do not support the hypothesis that the chronic hypertensive effects of Ang II in normal rats are altered by co-administration of either Ang(1-7) or A-779.
Santos RA, Ferreira AJ, Simoes e Silva ACRecent advances in the angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis. Exp Physiol2008;93:519-27.
2.
Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DICounterregulatory actions of angiotensin-(1-7). Hypertension1997;30:535-41.
3.
Tipnis SR, Hooper NM, Hyde R., Karran E., Christie G., Turner AJA human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captoprilinsensitive carboxypeptidase. J Biol Chem2000;275:33238-43.
4.
Donoghue M., Hsieh F., Baronas E. et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res2000;87(5):E1-9.
5.
Chappell MCEmerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?Hypertension2007;50:596-9.
6.
Santos A., Simoes e Silva AC, Silva DM et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A2003 ;100:8258-63.
7.
Brosnihan KB, Li P., Ferrario CMAngiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension1996;27:523-8.
8.
Porsti I., Bara AT, Busse R., Hecker M.Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol1994;111:652-4.
9.
Osei SY, Ahima RS, Minkews RK, Weaver JP, Khosla MC, Kadowitz PJDifferential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol1993;234(1):35-42.
le Tran Y., Forster C.Angiotensin-(1-7) and the rat aorta: modulation by the endothelium. J Cardiovasc Pharmacol1997;30:676-82.
12.
Ferreira AJ , Santos RACardiovascular actions of angiotensin-(1-7) . Braz J Med Biol Res2005;38:499-507.
13.
Grobe JL, Mecca AP, Lingis M. et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7) . Am J Physiol Heart Circ Physiol2007;292:H736-42.
14.
Huentelman MJ, Grobe JL, Vazquez J. et al. Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp Physiol2005;90:783-90.
15.
Diez-Freire C., Vazquez J., Correa de Adjounian MF et al. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol Genomics2006;27(1):12-19.
16.
Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CMVasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension1998;31:699-705.
17.
Iyer SN, Yamada K., Diz DI, Ferrario CM, Chappell MCEvidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J Cardiovasc Pharmacol2000;36: 109-17.
18.
Collister JP , Hendel MDThe role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats. J Renin Angiotensin Aldosterone Syst2003;4:176-9.
19.
Widdop RE, Sampey DB, Jarrott B.Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats. Hypertension1999;34:964-8.
20.
Benter IF, Ferrario CM, Morris M., Diz DIAntihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol1995;269:H313-19.
21.
Collister JP , Hendel MDRole of the subfornical organ in the chronic hypotensive response to losartan in normal rats. Hypertension2003;41:576-82.
22.
Ployngam T. , Collister JPAn intact median preoptic nucleus is necessary for chronic angiotensin II-induced hypertension. Brain Res2007;1162:69-75.
23.
Ployngam T. , Collister JPRole of the median preoptic nucleus in chronic angiotensin II-induced hypertension. Brain Res2008;1238:75-84.
24.
Hendel MD, Collister JPContribution of the subfornical organ to angiotensin II-induced hypertension . Am J Physiol Heart Circ Physiol2005;288:H680-5.
25.
Nahey DB, Collister JPANG II-induced hypertension and the role of the area postrema during normal and increased dietary salt. Am J Physiol Heart Circ Physiol2007;292:H694-700.
26.
Walters PE, Gaspari TA, Widdop REAngiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension2005;45:960-6.
27.
Benter IF, Yousif MH, Anim JT, Cojocel C., Diz DIAngiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am J Physiol Heart Circ Physiol2006;290:H684-91.
